159801-67-9

Upstream product

• 95260-60-9 (2S,4S)-benzyl 4-benzyl-5-oxo-2-phenyloxazolidine-3-carboxylate 
• 124-63-0 methanesulfonyl chloride 
• 159801-66-8 (2S,4R)-2-Phenyl-3-(carbobenzyloxy)-4-benzyl-4-(2-hydroxyethyl)oxazolidinone 

Downstream Products

• 159801-80-6 (2'R)-2-<<(2'-Benzyl-2',4'-diamino-1'-oxobutyl)amino>methyl>-1,3-dithiane 
• 159801-73-7 (4R,1'S)-2-<1'-<(Benzyloxycarbonyl)-amino>ethyl>-4-benzyl-4-carboxy-3,4,5,6-tetrahydropyrimidine 
• 159801-74-8 (4R,1'S)-2-<1'-<(benzyloxycarbonyl)-amino>ethyl>-4-benzyl-4-<<(2,2-dimethoxyethyl)amino>carbonyl>-3,4,5,6-tetrahydropyrimidine 
• 159801-77-1 (2R)-2-Benzyl-2,4-bis<(benzyloxycarbonyl)amino>butyric acid 
• 1028299-35-5 [(R)-3-Benzyloxycarbonylamino-3-(2,2-dimethoxy-ethylcarbamoyl)-4-phenyl-butyl]-carbamic acid benzyl ester 
• 159801-79-3 (2'R)-2-<<<2'-Benzyl-2',4'-bis<(benzyloxycarbonyl)amino>-1'-oxobutyl>amino>methyl>-1,3-dithiane 
• 159801-68-0 (2S,4R)-2-Phenyl-3-(carbobenzyloxy)-4-(2-azidoethyl)-4-benzyloxazolidinone 

Relevant academic research and scientific papers

Design and Synthesis of a Conformationally Restricted Cysteine Protease Inhibitor

Using the X-ray analyses of papain and papain-chloromethyl ketone inhibitor complexes as representative cysteine protease structures, molecular graphics analyses were applied to design (4R,1'S)-2-ethyl>-4-benzyl-4-(2-oxoeth